Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.35 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | FAAH | O00519 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30900231 | 0.89 | TLR2 (0.34) | — | |
| SCHEMBL30900148 | 0.89 | TLR2 (0.34) | — | |
| SCHEMBL30900159 | 0.89 | TLR2 (0.34) | — | |
| SCHEMBL30900224 | 0.88 | MGLL (0.35) | MGLLEPHX2CNR1ALDH1A1MAPT | |
| SCHEMBL30900235 | 0.88 | TLR2 (0.32) | ALDH1A1 | |
| SCHEMBL30900226 | 0.87 | TLR2 (0.33) | FAAH | |
| SCHEMBL30900218 | 0.85 | TLR2 (0.33) | ALDH1A1 | |
| SCHEMBL30900168 | 0.85 | PPARG (0.35) | EPHX2ALDH1A1 | |
| SCHEMBL31106605 | 0.83 | EPHX2 (0.36) | EPHX2CNR1ALDH1A1CNR2FAAH | |
| SCHEMBL30132389 | 0.83 | EPHX2 (0.36) | EPHX2CNR1ALDH1A1CNR2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115139-A1 | Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | NANOVATION THERAPEUTICS INC. (CA) | 2026-04-30 | — | — | US | disclosed |
| EP-4594293-A1 | AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS | Nanovation Therapeutics Inc. (CA) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024065043-A1 | AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2024-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115139-A1 | Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | SLC43A1, SLC7A1, SLC7A5 | MGLL 660/4885EPHX2 1404/4885CNR1 2886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.